Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting Janssen and Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast for investors and other interested parties on Saturday, November 10, at ...

NEW BRUNSWICK, N.J. , Nov. 2, 2012 /PRNewswire/ -- Janssen and Johnson & Johnson (NYSE: JNJ ) will provide a pre-recorded webcast for investors and other interested parties on Saturday, November 10 , at approximately 5:00 p.m., Eastern Time , to coincide with the American College of Rheumatology (ACR) Annual Meeting being held in Washington , D.C.

The presentation will highlight new, pivotal Phase 3 study findings, including;

The pre-recorded webcast with management from the Company's Janssen pharmaceutical subsidiaries, will provide an update on the Immunology rheumatology pipeline and commercial franchise.

The webcast/podcast can be accessed by visiting the Johnson & Johnson website at www.investor.jnj.com and clicking on "Webcasts/Presentations."

SOURCE Johnson & Johnson